Acasti Pharma Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Acasti Pharma Inc with three other
companies in this sector in Canada:
Eyecarrot Innovations Corp
sales of 67,629.00 Canadian Dollars [US$52,588.31 ]
Pacgen Life Science Corporation
(65,611.00 Canadian Dollars [US$51,019.11 ]
Novoheart Holdings Inc
(10,150.00 Canadian Dollars [US$7,892.64 ]
Sales fell dramatically in 2016:
During the year ended March of 2016, sales at
Acasti Pharma Inc were C$37,656.00 (US$29.28 thousand).
decrease of 86.1%
versus 2015, when the company's sales were C$270,615.00 .